Pacific Biosciences Of California (PACB) Inventory Average (2011 - 2026)

Pacific Biosciences Of California has reported Inventory Average for 16 years, with the latest figure at $56.1 million in Q2 2026.

• On a quarterly basis, Inventory Average rose 3.95% year-over-year to $56.1 million in Q2 2026; TTM through Jun 2026 was $56.1 million, a 3.95% increase from a year earlier, with the FY2025 full-year figure at $54.0 million, down 6.4% from the prior year.
• Inventory Average was $56.1 million for Q2 2026 at Pacific Biosciences Of California, up from $50.2 million in the prior quarter.
• The five-year high for Inventory Average was $68.0 million in Q2 2024, with the low at $27.1 million in Q1 2022.
• Average Inventory Average over 5 years is $54.4 million, with a median of $56.1 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Inventory Average soared 107.17% in 2023, then slipped 20.66% in 2025.
• Over 5 years, Inventory Average stood at $46.9 million in 2022, then jumped by 33.08% to $62.5 million in 2023, then dropped by 0.35% to $62.2 million in 2024, then fell by 17.72% to $51.2 million in 2025, then rose by 9.44% to $56.1 million in 2026.
• The last three Inventory Average figures came in at $56.1 million (Q2 2026), $50.2 million (Q1 2026), and $51.2 million (Q4 2025), per Business Quant data.